Implementation of Heart Transplantation Program to Advanced Heart Failure Patients in Brazil

Fabiana G Marcondes-Braga1, Marcely Gimenes Bonatto2, Caio Ribeiro Alves Andrade3

  • 1Heart Transplantation Department, Heart Institute (InCor), University of Sao Paulo, Sao Paulo, Brazil. fgmarcondes@yahoo.com.br.

Insights

Heart transplantation is crucial for advanced heart failure. Strategies are needed to shorten transplant waiting lists, especially in developing nations where devices like LVADs are less accessible.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Health Services Research

Background:

  • Heart transplantation is the definitive treatment for end-stage heart failure.
  • Left ventricular assist devices (LVADs) offer an alternative but face accessibility challenges in developing countries.
  • Increasing heart transplant waiting times necessitate innovative strategies, even with rising transplant volumes.

Purpose of the Study:

  • To survey heart transplant centers in Brazil, a developing country, to understand advanced heart failure treatment.
  • To identify opportunities for improving the heart transplant process and reducing waiting times.
  • To present a successful heart transplant team model.

Main Methods:

  • A survey was conducted across major Brazilian heart transplant centers.
  • Data on transplant processes and team structures were collected.
  • A model heart transplant team was described and benchmarked.

Main Results:

  • This is the first comprehensive survey of heart transplant centers in Brazil.
  • Optimizing transplant organization, multidisciplinary collaboration, donor care, and pre-transplant evaluation are key.
  • A specific heart transplant team model demonstrated success compared to leading Latin American centers.

Conclusions:

  • Improving transplant logistics and team efficiency can enhance outcomes for advanced heart failure.
  • The presented model offers a viable strategy for developing countries to optimize heart transplantation.
  • Addressing waiting list challenges requires systemic improvements in care delivery.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
894
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
865
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
329
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
963
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
305